The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Lacosamide Market Research Report 2024

Global Lacosamide Market Research Report 2024

Publishing Date : Jul, 2022

License Type :
 

Report Code : 1400065

No of Pages : 88

Synopsis
Market Analysis and Insights: Global Lacosamide Market
Lacosamide (INN, formerly known as erlosamide, harkeroside, SPM 927, or ADD 234037), is a medication for the adjunctive treatment of partial-onset seizures and diabetic neuropathic pain. It is marketed under the trade name Vimpat.
The global Lacosamide market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Oral tablets accounting for % of the Lacosamide global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Adults segment is altered to an % CAGR throughout this forecast period.
China Lacosamide market size is valued at US$ million in 2021, while the North America and Europe Lacosamide are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Lacosamide landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Lacosamide market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Lacosamide market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Lacosamide market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Lacosamide market.
Global Lacosamide Scope and Market Size
Lacosamide market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Lacosamide market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Oral tablets
Oral solution
Intravenous
Segment by Application
Adults
Pediatric patients
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
UCB
Teva
Amneal Pharmaceuticals
MSN Laboratories
Alembic Pharma
Glenmark
Aurobindo Pharma
Accord Healthcare
Mylan
Sun Pharma
Apotex
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Lacosamide Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Oral tablets
1.2.3 Oral solution
1.2.4 Intravenous
1.3 Market by Application
1.3.1 Global Lacosamide Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Adults
1.3.3 Pediatric patients
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Lacosamide Market Perspective (2017-2028)
2.2 Lacosamide Growth Trends by Region
2.2.1 Lacosamide Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Lacosamide Historic Market Size by Region (2017-2022)
2.2.3 Lacosamide Forecasted Market Size by Region (2023-2028)
2.3 Lacosamide Market Dynamics
2.3.1 Lacosamide Industry Trends
2.3.2 Lacosamide Market Drivers
2.3.3 Lacosamide Market Challenges
2.3.4 Lacosamide Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Lacosamide Players by Revenue
3.1.1 Global Top Lacosamide Players by Revenue (2017-2022)
3.1.2 Global Lacosamide Revenue Market Share by Players (2017-2022)
3.2 Global Lacosamide Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Lacosamide Revenue
3.4 Global Lacosamide Market Concentration Ratio
3.4.1 Global Lacosamide Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Lacosamide Revenue in 2021
3.5 Lacosamide Key Players Head office and Area Served
3.6 Key Players Lacosamide Product Solution and Service
3.7 Date of Enter into Lacosamide Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Lacosamide Breakdown Data by Type
4.1 Global Lacosamide Historic Market Size by Type (2017-2022)
4.2 Global Lacosamide Forecasted Market Size by Type (2023-2028)
5 Lacosamide Breakdown Data by Application
5.1 Global Lacosamide Historic Market Size by Application (2017-2022)
5.2 Global Lacosamide Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Lacosamide Market Size (2017-2028)
6.2 North America Lacosamide Market Size by Country (2017-2022)
6.3 North America Lacosamide Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Lacosamide Market Size (2017-2028)
7.2 Europe Lacosamide Market Size by Country (2017-2022)
7.3 Europe Lacosamide Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Lacosamide Market Size (2017-2028)
8.2 Asia-Pacific Lacosamide Market Size by Country (2017-2022)
8.3 Asia-Pacific Lacosamide Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Lacosamide Market Size (2017-2028)
9.2 Latin America Lacosamide Market Size by Country (2017-2022)
9.3 Latin America Lacosamide Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Lacosamide Market Size (2017-2028)
10.2 Middle East & Africa Lacosamide Market Size by Country (2017-2022)
10.3 Middle East & Africa Lacosamide Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 UCB
11.1.1 UCB Company Detail
11.1.2 UCB Business Overview
11.1.3 UCB Lacosamide Introduction
11.1.4 UCB Revenue in Lacosamide Business (2017-2022)
11.1.5 UCB Recent Development
11.2 Teva
11.2.1 Teva Company Detail
11.2.2 Teva Business Overview
11.2.3 Teva Lacosamide Introduction
11.2.4 Teva Revenue in Lacosamide Business (2017-2022)
11.2.5 Teva Recent Development
11.3 Amneal Pharmaceuticals
11.3.1 Amneal Pharmaceuticals Company Detail
11.3.2 Amneal Pharmaceuticals Business Overview
11.3.3 Amneal Pharmaceuticals Lacosamide Introduction
11.3.4 Amneal Pharmaceuticals Revenue in Lacosamide Business (2017-2022)
11.3.5 Amneal Pharmaceuticals Recent Development
11.4 MSN Laboratories
11.4.1 MSN Laboratories Company Detail
11.4.2 MSN Laboratories Business Overview
11.4.3 MSN Laboratories Lacosamide Introduction
11.4.4 MSN Laboratories Revenue in Lacosamide Business (2017-2022)
11.4.5 MSN Laboratories Recent Development
11.5 Alembic Pharma
11.5.1 Alembic Pharma Company Detail
11.5.2 Alembic Pharma Business Overview
11.5.3 Alembic Pharma Lacosamide Introduction
11.5.4 Alembic Pharma Revenue in Lacosamide Business (2017-2022)
11.5.5 Alembic Pharma Recent Development
11.6 Glenmark
11.6.1 Glenmark Company Detail
11.6.2 Glenmark Business Overview
11.6.3 Glenmark Lacosamide Introduction
11.6.4 Glenmark Revenue in Lacosamide Business (2017-2022)
11.6.5 Glenmark Recent Development
11.7 Aurobindo Pharma
11.7.1 Aurobindo Pharma Company Detail
11.7.2 Aurobindo Pharma Business Overview
11.7.3 Aurobindo Pharma Lacosamide Introduction
11.7.4 Aurobindo Pharma Revenue in Lacosamide Business (2017-2022)
11.7.5 Aurobindo Pharma Recent Development
11.8 Accord Healthcare
11.8.1 Accord Healthcare Company Detail
11.8.2 Accord Healthcare Business Overview
11.8.3 Accord Healthcare Lacosamide Introduction
11.8.4 Accord Healthcare Revenue in Lacosamide Business (2017-2022)
11.8.5 Accord Healthcare Recent Development
11.9 Mylan
11.9.1 Mylan Company Detail
11.9.2 Mylan Business Overview
11.9.3 Mylan Lacosamide Introduction
11.9.4 Mylan Revenue in Lacosamide Business (2017-2022)
11.9.5 Mylan Recent Development
11.10 Sun Pharma
11.10.1 Sun Pharma Company Detail
11.10.2 Sun Pharma Business Overview
11.10.3 Sun Pharma Lacosamide Introduction
11.10.4 Sun Pharma Revenue in Lacosamide Business (2017-2022)
11.10.5 Sun Pharma Recent Development
11.11 Apotex
11.11.1 Apotex Company Detail
11.11.2 Apotex Business Overview
11.11.3 Apotex Lacosamide Introduction
11.11.4 Apotex Revenue in Lacosamide Business (2017-2022)
11.11.5 Apotex Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
List of Tables
Table 1. Global Lacosamide Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Oral tablets
Table 3. Key Players of Oral solution
Table 4. Key Players of Intravenous
Table 5. Global Lacosamide Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Lacosamide Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Lacosamide Market Size by Region (2017-2022) & (US$ Million)
Table 8. Global Lacosamide Market Share by Region (2017-2022)
Table 9. Global Lacosamide Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 10. Global Lacosamide Market Share by Region (2023-2028)
Table 11. Lacosamide Market Trends
Table 12. Lacosamide Market Drivers
Table 13. Lacosamide Market Challenges
Table 14. Lacosamide Market Restraints
Table 15. Global Lacosamide Revenue by Players (2017-2022) & (US$ Million)
Table 16. Global Lacosamide Market Share by Players (2017-2022)
Table 17. Global Top Lacosamide Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lacosamide as of 2021)
Table 18. Ranking of Global Top Lacosamide Companies by Revenue (US$ Million) in 2021
Table 19. Global 5 Largest Players Market Share by Lacosamide Revenue (CR5 and HHI) & (2017-2022)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Lacosamide Product Solution and Service
Table 22. Date of Enter into Lacosamide Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Lacosamide Market Size by Type (2017-2022) & (US$ Million)
Table 25. Global Lacosamide Revenue Market Share by Type (2017-2022)
Table 26. Global Lacosamide Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 27. Global Lacosamide Revenue Market Share by Type (2023-2028)
Table 28. Global Lacosamide Market Size by Application (2017-2022) & (US$ Million)
Table 29. Global Lacosamide Revenue Market Share by Application (2017-2022)
Table 30. Global Lacosamide Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 31. Global Lacosamide Revenue Market Share by Application (2023-2028)
Table 32. North America Lacosamide Market Size by Country (2017-2022) & (US$ Million)
Table 33. North America Lacosamide Market Size by Country (2023-2028) & (US$ Million)
Table 34. Europe Lacosamide Market Size by Country (2017-2022) & (US$ Million)
Table 35. Europe Lacosamide Market Size by Country (2023-2028) & (US$ Million)
Table 36. Asia-Pacific Lacosamide Market Size by Region (2017-2022) & (US$ Million)
Table 37. Asia-Pacific Lacosamide Market Size by Region (2023-2028) & (US$ Million)
Table 38. Latin America Lacosamide Market Size by Country (2017-2022) & (US$ Million)
Table 39. Latin America Lacosamide Market Size by Country (2023-2028) & (US$ Million)
Table 40. Middle East & Africa Lacosamide Market Size by Country (2017-2022) & (US$ Million)
Table 41. Middle East & Africa Lacosamide Market Size by Country (2023-2028) & (US$ Million)
Table 42. UCB Company Detail
Table 43. UCB Business Overview
Table 44. UCB Lacosamide Product
Table 45. UCB Revenue in Lacosamide Business (2017-2022) & (US$ Million)
Table 46. UCB Recent Development
Table 47. Teva Company Detail
Table 48. Teva Business Overview
Table 49. Teva Lacosamide Product
Table 50. Teva Revenue in Lacosamide Business (2017-2022) & (US$ Million)
Table 51. Teva Recent Development
Table 52. Amneal Pharmaceuticals Company Detail
Table 53. Amneal Pharmaceuticals Business Overview
Table 54. Amneal Pharmaceuticals Lacosamide Product
Table 55. Amneal Pharmaceuticals Revenue in Lacosamide Business (2017-2022) & (US$ Million)
Table 56. Amneal Pharmaceuticals Recent Development
Table 57. MSN Laboratories Company Detail
Table 58. MSN Laboratories Business Overview
Table 59. MSN Laboratories Lacosamide Product
Table 60. MSN Laboratories Revenue in Lacosamide Business (2017-2022) & (US$ Million)
Table 61. MSN Laboratories Recent Development
Table 62. Alembic Pharma Company Detail
Table 63. Alembic Pharma Business Overview
Table 64. Alembic Pharma Lacosamide Product
Table 65. Alembic Pharma Revenue in Lacosamide Business (2017-2022) & (US$ Million)
Table 66. Alembic Pharma Recent Development
Table 67. Glenmark Company Detail
Table 68. Glenmark Business Overview
Table 69. Glenmark Lacosamide Product
Table 70. Glenmark Revenue in Lacosamide Business (2017-2022) & (US$ Million)
Table 71. Glenmark Recent Development
Table 72. Aurobindo Pharma Company Detail
Table 73. Aurobindo Pharma Business Overview
Table 74. Aurobindo Pharma Lacosamide Product
Table 75. Aurobindo Pharma Revenue in Lacosamide Business (2017-2022) & (US$ Million)
Table 76. Aurobindo Pharma Recent Development
Table 77. Accord Healthcare Company Detail
Table 78. Accord Healthcare Business Overview
Table 79. Accord Healthcare Lacosamide Product
Table 80. Accord Healthcare Revenue in Lacosamide Business (2017-2022) & (US$ Million)
Table 81. Accord Healthcare Recent Development
Table 82. Mylan Company Detail
Table 83. Mylan Business Overview
Table 84. Mylan Lacosamide Product
Table 85. Mylan Revenue in Lacosamide Business (2017-2022) & (US$ Million)
Table 86. Mylan Recent Development
Table 87. Sun Pharma Company Detail
Table 88. Sun Pharma Business Overview
Table 89. Sun Pharma Lacosamide Product
Table 90. Sun Pharma Revenue in Lacosamide Business (2017-2022) & (US$ Million)
Table 91. Sun Pharma Recent Development
Table 92. Apotex Company Detail
Table 93. Apotex Business Overview
Table 94. Apotex LacosamideProduct
Table 95. Apotex Revenue in Lacosamide Business (2017-2022) & (US$ Million)
Table 96. Apotex Recent Development
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Lacosamide Market Share by Type: 2021 VS 2028
Figure 2. Oral tablets Features
Figure 3. Oral solution Features
Figure 4. Intravenous Features
Figure 5. Global Lacosamide Market Share by Application in 2021 & 2028
Figure 6. Adults Case Studies
Figure 7. Pediatric patients Case Studies
Figure 8. Lacosamide Report Years Considered
Figure 9. Global Lacosamide Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 10. Global Lacosamide Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Lacosamide Market Share by Region: 2021 VS 2028
Figure 12. Global Lacosamide Market Share by Players in 2021
Figure 13. Global Top Lacosamide Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lacosamide as of 2021)
Figure 14. The Top 10 and 5 Players Market Share by Lacosamide Revenue in 2021
Figure 15. North America Lacosamide Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 16. North America Lacosamide Market Share by Country (2017-2028)
Figure 17. United States Lacosamide Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 18. Canada Lacosamide Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. Europe Lacosamide Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Europe Lacosamide Market Share by Country (2017-2028)
Figure 21. Germany Lacosamide Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. France Lacosamide Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. U.K. Lacosamide Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Italy Lacosamide Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Russia Lacosamide Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Nordic Countries Lacosamide Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Asia-Pacific Lacosamide Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Asia-Pacific Lacosamide Market Share by Region (2017-2028)
Figure 29. China Lacosamide Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Japan Lacosamide Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. South Korea Lacosamide Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Southeast Asia Lacosamide Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. India Lacosamide Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Australia Lacosamide Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Latin America Lacosamide Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Latin America Lacosamide Market Share by Country (2017-2028)
Figure 37. Mexico Lacosamide Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Brazil Lacosamide Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Middle East & Africa Lacosamide Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Middle East & Africa Lacosamide Market Share by Country (2017-2028)
Figure 41. Turkey Lacosamide Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Saudi Arabia Lacosamide Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. UCB Revenue Growth Rate in Lacosamide Business (2017-2022)
Figure 44. Teva Revenue Growth Rate in Lacosamide Business (2017-2022)
Figure 45. Amneal Pharmaceuticals Revenue Growth Rate in Lacosamide Business (2017-2022)
Figure 46. MSN Laboratories Revenue Growth Rate in Lacosamide Business (2017-2022)
Figure 47. Alembic Pharma Revenue Growth Rate in Lacosamide Business (2017-2022)
Figure 48. Glenmark Revenue Growth Rate in Lacosamide Business (2017-2022)
Figure 49. Aurobindo Pharma Revenue Growth Rate in Lacosamide Business (2017-2022)
Figure 50. Accord Healthcare Revenue Growth Rate in Lacosamide Business (2017-2022)
Figure 51. Mylan Revenue Growth Rate in Lacosamide Business (2017-2022)
Figure 52. Sun Pharma Revenue Growth Rate in Lacosamide Business (2017-2022)
Figure 53. Apotex Revenue Growth Rate in Lacosamide Business (2017-2022)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’